Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed1
Recruiting2
Other1

Role Distribution

Principal Investigator2
Other Roles2
PI Rate50%

Activity Timeline

Clinical Trials (4)

NCT05583006Recruiting
Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Drug AdherenceEfficacy, SelfPatient Satisfaction+1 more
PrincipalinvestigatorStart date: 2023-11-06
NCT05410496Phase 4Active Not Recruiting
Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection
Chronic Hepatitis BSafety IssuesTransplant Recipient
PrincipalinvestigatorStart date: 2021-06-22
NCT03933384Phase 4Recruiting
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Hepatitis BViral Hepatitis
StudychairStart date: 2019-08-19
NCT02582333Completed
Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy
PrognosisVirological Breakthrough
StudychairStart date: 2015-10-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05583006PrincipalInvestigator

Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B

Drug AdherenceEfficacy, SelfPatient Satisfaction+1 more
Recruiting
NCT05410496Phase 4PrincipalInvestigator

Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection

Chronic Hepatitis BSafety IssuesTransplant Recipient
Active Not Recruiting
NCT03933384Phase 4StudyChair

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

Hepatitis BViral Hepatitis
Recruiting
NCT02582333StudyChair

Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy

PrognosisVirological Breakthrough
Completed

All 4 trials loaded